Choroidal Neovascularization
📧 Sign up to get email alerts when something new happens for Choroidal Neovascularization.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)
This completed trial compares Foresee Home with Optical Coherence Tomography (OCT) in detecting visual field defects in patients with choroi…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration [Phase 1, Phase 2]
Phase 1/2 trial evaluating an ocular sirolimus (rapamycin) formulation for age-related macular degeneration with choroidal neovascularizatio…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration [Phase 2]
Phase 2 study of ocular sirolimus in combination with Lucentis for age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration [Phase 4]
Phase 4 clinical trial update evaluating reduced fluence photodynamic therapy with Visudyne in combination with Lucentis for age-related mac…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial [Phase 1]
Phase 1 clinical trial update for ranibizumab in hemorrhagic choroidal neovascularization, with results posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial evaluating an adjunctive therapy to anti-VEGF for wet age-related macular degeneration. The study has completed and results we…
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial update evaluating a new adjunctive therapy to anti-VEGF for age-related macular degeneration; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Photodynamic and Pharmacologic Treatment of CNV [Phase 1, Phase 2]
This clinical trial update notes the completion of Phase 1 and Phase 2 studies investigating photodynamic and pharmacologic approaches to tr…
-
CLINICAL_TRIALS withdrawal · 2012-07-02Clinical Trial Update: Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks [Phase 1, Phase 2]
The Phase 1/2 clinical trial of ranibizumab for choroidal neovascularization associated with angioid streaks has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration [Phase 4]
Phase 4 clinical trial evaluating the safety and efficacy of ranibizumab in patients with choroidal neovascularization due to causes other t…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy [NA]
This completed clinical trial evaluated whether vitreous composition, as determined by ultrasound and OCT, influences ranibizumab therapy fo…
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) [Phase 2]
Phase 2 trial evaluating ranibizumab for choroidal neovascularization in patients with pseudoxanthoma elasticum has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]
Phase 2 clinical trial evaluating intravitreal adalimumab for choroidal neovascularization secondary to age-related macular degeneration has…
-
CLINICAL_TRIALS research · 2012-02-13Clinical Trial Update: A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye [NA]
A clinical trial update investigating the effects of repeated intravitreal injections on bacteria around the eye, with conditions including …
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO [NA]
An extension study assessing the safety and tolerability of Ranibizumab in subjects with choroidal neovascularization related to age-related…
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 2]
Phase 2 trial assessing safety and efficacy of Combretastatin A4 Phosphate for choroidal neovascularization secondary to pathologic myopia h…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study [Phase 1]
Phase 1 pilot study evaluating intravitreal adalimumab for refractory diabetic retinopathy, choroidal neovascularization, or uveitis.
-
CLINICAL_TRIALS trial_result · 2011-05-27Clinical Trial Update: Optic Nerve and Retinal Functions With Bevacizumab
This trial update reports on optic nerve and retinal function outcomes in eyes with choroidal neovascularization treated with bevacizumab.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib [Phase 3]
A Phase 3 trial comparing verteporfin PDT plus intravitreal triamcinolone versus verteporfin PDT plus intravitreal pegaptanib for age-relate…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization [Phase 3]
Phase 3 trial evaluating verteporfin photodynamic therapy added to ranibizumab versus ranibizumab alone for subfoveal choroidal neovasculari…
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration [Phase 2]
A Phase 2 clinical trial evaluated infliximab, sirolimus, and daclizumab for age-related macular degeneration, with results posted after com…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Bevacizumab Effect on Blood Velocity
A completed clinical trial evaluating how bevacizumab affects blood velocity in choroidal neovascularization.
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating verteporfin photodynamic therapy in combination with ranibizumab for subfoveal choroidal neovascularization due…
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration [Phase 3]
This update reports the completion and posted results of the Phase 3 SUSTAIN trial evaluating ranibizumab for subfoveal choroidal neovascula…
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD [Phase 4]
Open-label Phase 4 trial of Macugen in subjects with neovascular age-related macular degeneration was terminated; results have been posted.